Robert M Straubinger

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Squamous Cell Carcinoma

Intellectual Disability

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Life (Basel, Switzerland)

The Journal of pharmacology and experimental therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Tista Roy Chaudhuri, Qingxiang Lin, Ewa K Stachowiak, Spencer R Rosario, Joseph A Spernyak, Wen Wee Ma, Michal K Stachowiak, Michelle K Greene, Gerard P Quinn, Simon S McDade, Martin Clynes, Christopher J Scott, Robert M Straubinger
Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Tista Roy Chaudhuri, Qingxiang Lin, Ewa K Stachowiak, Spencer R Rosario, Joseph A Spernyak, Wen Wee Ma, Michal K Stachowiak, Michelle K Greene, Gerard P Quinn, Simon S McDade, Martin Clynes, Christopher J Scott, Robert M Straubinger
Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Tista Roy Chaudhuri, Qingxiang Lin, Ewa K Stachowiak, Spencer R Rosario, Joseph A Spernyak, Wen Wee Ma, Michal K Stachowiak, Michelle K Greene, Gerard P Quinn, Simon S McDade, Martin Clynes, Christopher J Scott, Robert M Straubinger
Dual-hit strategy for therapeutic targeting of pancreatic cancer in patient-derived xenograft tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Tista Roy Chaudhuri, Qingxiang Lin, Ewa K Stachowiak, Spencer R Rosario, Joseph A Spernyak, Wen Wee Ma, Michal K Stachowiak, Michelle K Greene, Gerard P Quinn, Simon S McDade, Martin Clynes, Christopher J Scott, Robert M Straubinger
Dual-hit strategy for therapeutic targeting of pancreatic cancer in patient-derived xenograft tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Tista Roy Chaudhuri, Qingxiang Lin, Ewa K Stachowiak, Spencer R Rosario, Joseph A Spernyak, Wen Wee Ma, Michal K Stachowiak, Michelle K Greene, Gerard P Quinn, Simon S McDade, Martin Clynes, Christopher J Scott, Robert M Straubinger
Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Fiona O'Neill, Taylor-Jade Allen-Coyle, Sandra Roche, Justine Meiller, Neil T Conlon, Niall Swan, Robert M Straubinger, Justin Geoghegan, Ninfa L Straubinger, Kevin Conlon, Ray S McDermott, Finbarr O'Sullivan, Michael Henry, Paula Meleady, Gerard McVey, Robert O'Connor, Michael Moriarty, Martin Clynes
Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These Tumors. Life (Basel, Switzerland) 13 (3) (2023)
Fiona O'Neill, Taylor-Jade Allen-Coyle, Sandra Roche, Justine Meiller, Neil T Conlon, Niall Swan, Robert M Straubinger, Justin Geoghegan, Ninfa L Straubinger, Kevin Conlon, Ray S McDermott, Finbarr O'Sullivan, Michael Henry, Paula Meleady, Gerard McVey, Robert O'Connor, Michael Moriarty, Martin Clynes
Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These Tumors. Life (Basel, Switzerland) 13 (3) (2023)
Qingxiang Lin, Andrea Serratore, Jonathan Perri, Tista Roy Chaudhuri, Jun Qu, Wen Wee Ma, Eugene Kandel, Robert M Straubinger
FGFR1 expression correlates inversely with the efficacy of single-agent FGFR-specific inhibitors in pancreatic cancer. British journal of pharmacology (2023)
Fiona O'Neill, Taylor-Jade Allen-Coyle, Sandra Roche, Justine Meiller, Neil T Conlon, Niall Swan, Robert M Straubinger, Justin Geoghegan, Ninfa L Straubinger, Kevin Conlon, Ray S McDermott, Finbarr O'Sullivan, Michael Henry, Paula Meleady, Gerard McVey, Robert O'Connor, Michael Moriarty, Martin Clynes
Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These Tumors. Life (Basel, Switzerland) 13 (3) (2023)
Qingxiang Lin, Zhicheng Qian, William J Jusko, Donald E Mager, Wen Wee Ma, Robert M Straubinger
Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation. The Journal of pharmacology and experimental therapeutics 377 (3) (2021)
Jin Niu, Xue Wang, Jun Qu, Donald E Mager, Robert M Straubinger
Pharmacodynamic modeling of synergistic birinapant/paclitaxel interactions in pancreatic cancer cells. BMC cancer 20 (1) (2020)
Jun Wang, Darren K W Chan, Arindam Sen, Wen Wee Ma, Robert M Straubinger
Tumor Priming by SMO Inhibition Enhances Antibody Delivery and Efficacy in a Pancreatic Ductal Adenocarcinoma Model. Molecular cancer therapeutics 18 (11) (2019)
Adam J Camblin, Emily A Pace, Sharlene Adams, Michael D Curley, Victoria Rimkunas, Lin Nie, Gege Tan, Troy Bloom, Sergio Iadevaia, Jason Baum, Charlene Minx, Akos Czibere, Chrystal U Louis, Daryl C Drummond, Ulrik B Nielsen, Birgit Schoeberl, J Marc Pipas, Robert M Straubinger, Vasileios Askoxylakis, Alexey A Lugovskoy
Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (12) (2018)